Suppr超能文献

劳拉西泮:猫体内的葡萄糖醛酸结合反应

Lorazepam: glucuronide formation in the cat.

作者信息

Schillings R T, Sisenwine S F, Schwartz M H, Ruelius H W

出版信息

Drug Metab Dispos. 1975 Mar-Apr;3(2):85-8.

PMID:236163
Abstract

The excretion and metabolism of lorazepam was studied in domestic cats. After oral administration of 14-C-lorazepam (1 mg/kg), the mean percent of the dose excreted in urine was 47.3 plus or minus 6.7% (SD) and in feces 54.0 plus or minus 6.1% (SD). The main urinary metabolite was lorazepam glucuronide; its mean excretion over the first 3 days amounted to 29% of the dose (66% of urinary radioactivity). When 20 mg of unlabeled drug per kg was given, about 40% of the dose was excreted into urine as lorazepam glucuronide within 6 days. Conculsive evidence for the glucuronide structure was obtained by chemical analysis and mass spectrometry of the lorazepam conjugate isolated from cat urine. The radioactivity in urine which was not attributable to several minor metabolites. In plasma, both lorazepam and lorazepam glucuronide were present. These findings indicate that the cat is capable of using glucuronidation as a major route of conjugation, contrary to the many reports that cats conjugate exogenous materials poorly with glucuronic acid.

摘要

研究了劳拉西泮在家猫体内的排泄和代谢情况。口服给予14-C-劳拉西泮(1毫克/千克)后,经尿液排泄的剂量平均百分比为47.3±6.7%(标准差),经粪便排泄的为54.0±6.1%(标准差)。主要的尿液代谢产物是劳拉西泮葡萄糖醛酸苷;头3天其平均排泄量达剂量的29%(占尿液放射性的66%)。当每千克给予20毫克未标记药物时,约40%的剂量在6天内以劳拉西泮葡萄糖醛酸苷的形式排泄到尿液中。通过对从猫尿液中分离出的劳拉西泮结合物进行化学分析和质谱分析,获得了葡萄糖醛酸苷结构的确凿证据。尿液中的放射性并非归因于几种次要代谢产物。血浆中同时存在劳拉西泮和劳拉西泮葡萄糖醛酸苷。这些发现表明,与许多关于猫对外源性物质与葡萄糖醛酸结合能力较差的报道相反,猫能够将葡萄糖醛酸化作为主要的结合途径。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验